Skip to main content
Premium Trial:

Request an Annual Quote

John Crison

Premium
John Crison has Joined Simulations Plus as its director of life sciences.
The company, which offers simulation and modeling software for pharmaceutical discovery and development, announced that Crison replaces Michael Bolger, who has “served the company very well” for 11 years.
 
However, Bolger moved 350 miles from company offices in Lancaster, which was no longer in line with company needs.
 
”The telecommuting arrangement worked well when the team was smaller, but with our rapidly growing team here in Lancaster, he [Michael Bolger] and I agreed that we needed an on-site director,” said CEO Walt Woltosz in a statement.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people 65 and older or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.